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large thrombus burden. Indeed, a recent study 
comparing clinical and procedural characteristics 
among hospitals, mostly regarding elective per-
cutaneous coronary intervention, invariably report-
ed a contrast volume of more than 200 ml.5
Finally, the difference in the primary end point 
and the other clinical end points between the two 
N-acetylcysteine groups was significant when 
analyzed by the Mantel–Haenszel chi-square test 
for trend, suggesting a dose-dependent protective 
effect of N-acetylcysteine.
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Iodine Nutrition — More Is Better
To the Editor: The editorial by Utiger (June 29 
issue)1 summarizes the effects of iodine defi-
ciency. However, his recommendation of an iodine 
intake of 300 to 400 μg per day far exceeds the 
following recommendations of the Institute of 
Medicine: 150 μg per day for nonpregnant adults, 
220 μg per day for pregnant women, and 290 μg 
per day during lactation.2 Teng et al.3 found that 
an iodine intake of approximately 320 to 840 μg 
per day resulted in an increased incidence of sub-
clinical hypothyroidism and thyroid autoimmu-
nity. These risks may be clinically important — 
children of women with subclinical gestational 
hypothyroidism may have neurocognitive delays.4 
Utiger suggests that iodine intake in the United 
States is marginal on the basis of the prevalence 
of spot urinary iodine values under 50 μg per liter 
among pregnant women.5 However, iodine defi-
ciency may not be diagnosed from analysis of 
spot urine samples in individuals because of 
day-to-day variability. Median spot urinary io-
dine values accurately reflect the iodine nutri-
tion of populations, and the median value of 
168 μg per liter for the United States5 is consis-
tent with iodine sufficiency according to World 
Health Organization (WHO) criteria. We believe 
that the evidence supports the current guidelines 
for dietary iodine intake and that overall iodine 
intake in the United States remains sufficient.
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To the Editor: We fully agree with the title of 
Utiger’s editorial, “Iodine Nutrition — More Is 
Better,” but wish to comment on how much more 
is better during pregnancy and lactation.
In January 2005, the WHO held a technical 
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consultation on this point, and one of us was an 
invited speaker. The recommendation that emerged 
was for pregnant and lactating women to have 
250 instead of 200 μg of iodine daily,1 almost 
double the intake for the adult population. This 
results in urinary concentrations of 150 to 250 μg 
of iodine per liter. Even in areas with marginal 
iodine intake, the United States and Spain includ-
ed (Fig. 1 of the editorial), it is highly unlikely that 
pregnant and lactating women receive enough 
iodine2 for normal fetal neurodevelopment,3 un-
less daily supplements (i.e., 200 μg of iodine) are 
prescribed from the onset of pregnancy (or be-
fore). Such supplements taken during pregnancy 
and lactation would overcome changes of iodine 
intake through food and iodinated salt that fre-
quently occur after conception. Supplementation 
is being implemented in Spain, where Yoduk tab-
lets containing 200 μg of iodine (262 μg of po-
tassium iodide) are made available to pregnant 
and lactating women through the National Health 
System.
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The editorialist replies: My recommendation 
that daily iodine intake should be 300 to 400 μg 
does exceed the recommendations of the Institute 
of Medicine by a factor of two for men and non-
pregnant women, and less for pregnant and lac-
tating women, but it does not far exceed them, as 
stated by Drs. Pearce and Hollowell. My recom-
mendation was based on my concern about the 
increase by a factor of seven (from 1 to 7 percent) 
in the frequency of moderate iodine deficiency 
among pregnant women and also the increase by 
a factor of four (from 3 to 12 percent) in the fre-
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quency of moderate iodine deficiency in the total 
population, coincident with the decline of more 
than 50% in urinary iodine excretion in the United 
States from 1971–1974 to 1988–1994 (and from 
1971–1974 to 2001–2002).1 Raising the iodine in-
take to 300 to 400 μg daily should reduce the 
frequency of low values to the 1971–1974 levels.
Drs. Morreale de Escobar and Escobar del Rey 
endorse the need for increased iodine intake in 
pregnant women, and point out another way to 
achieve this. All prenatal vitamin preparations 
should contain iodine, and all pregnant women 
should take them. My preference, however, is to 
increase iodine intake for everyone.
As noted by Drs. Pearce and Hollowell, day-to-
day urinary iodine excretion varies within sub-
jects.2 However, low values cannot be dismissed 
as an exceptional finding; they are biologically 
important. For example, pregnant women with 
urinary iodine values of less than 50 μg per liter 
had larger thyroid glands and higher serum thy-
rotropin and thyroglobulin concentrations, indic-
ative of compensatory thyroid stimulation, than 
did pregnant women who were given a supplement 
of 100 μg of iodine daily.3 Similarly, at birth, 
their infants had larger thyroid glands and high-
er serum thyroglobulin concentrations than did 
the infants of mothers who received the supple-
ment. Although higher iodine intakes may be 
associated with very small increases in the preva-
lence and incidence of subclinical hypothyroid-
ism and autoimmune thyroiditis,4 it is more im-
portant to ensure that everyone, especially pregnant 
women, has an adequate iodine intake.
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